# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T16:23:47.113320
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 15791 in / 4175 out
**Response SHA256:** d8a911be7bcd9272

---

## Summary

The paper asks an important policy question—whether “constitutional carry” (permitless concealed carry) affects mortality—and brings modern staggered-adoption DiD tools plus placebo outcomes to bear. The headline result is that constitutional carry increases suicides (0.5–1.4 per 100,000), with firearm suicides rising and firearm homicides flat.

At a top general-interest journal standard, the paper is **not yet publication-ready** because (i) the *core identifying variation differs across panels and estimators*, (ii) the paper does not yet provide inference that is robust to **few treated clusters / staggered timing**, (iii) treatment measurement and timing (annual coding; mid-year implementation; “not-yet-treated controls” that are treated shortly after the sample ends) require tighter justification, and (iv) mechanism and welfare claims are currently **over-calibrated** relative to what the design can support.

Below I focus on scientific substance and readiness.

---

# 1. Identification and empirical design (critical)

### 1.1 What is the causal estimand, and is it consistent across panels?
- **Panel A (1999–2017)** identifies effects off **10 early-adopting states** (2010–2017) vs **(a) never-treated + (b) states treated after 2017 but coded as untreated within the window** (Data/Panel Construction; Strategy/Estimators).
- **Panel B (2019–2024)** identifies effects off **later adopters**, but with *very short pre-trends* and heavy overlap with the COVID era (Strategy/Threats to Validity).

These are not the same policy experiment. As written, the paper sometimes reads as if Panel B “confirms” the Panel A mechanism. It can, but only if you show that (i) the composition of adopting states and (ii) the dynamic effects are comparable. Right now, the link is asserted more than demonstrated.

**Concrete fix:** Explicitly define the main estimand (e.g., an average ATT over adopting states with ≥k post years) and show how each panel contributes evidence toward it (reduced form vs mechanism decomposition), including cohort weights.

### 1.2 Use of “not-yet-treated” states as controls in Panel A
Using states that adopt after 2017 as controls during 1999–2017 is common, but here it is unusually salient because many “controls” are *politically similar to treated states* and on the same deregulatory trajectory. That can help (better counterfactual) or hurt (anticipation / differential trend correlated with latent pro-gun movement).

The paper states “no anticipation” and points to event studies (Strategy/Threats). However:
- Anticipation in this setting could plausibly occur through **policy campaigning, NRA mobilization, and local enforcement posture** before formal effective dates.
- Event-study support is described qualitatively; I did not see a formal joint test of pre-trends or sensitivity to dropping the “event-time = −8” lead that is “marginally significant” (Strategy/Threats; Results/Event Study).

**Concrete fix:** Add (i) joint pre-trend tests, (ii) specifications that use *only never-treated* as controls in Panel A (even if less precise), and (iii) sensitivity excluding states that adopt shortly after 2017 (e.g., 2019 cohort) from the control group to assess “incipient adoption” bias.

### 1.3 Treatment timing and annual measurement
The paper codes a state-year as treated “at or after the adoption year” (Data/Treatment Timing; Data/Panel Construction). Many carry laws take effect mid-year; annual coding can induce:
- **Misclassification / attenuation** (partial exposure treated as full year), and
- Spurious “immediate” effects in event time 0 that are partly mechanical.

The paper also excludes LA/SC 2024 due to mid-year timing concerns, which underscores that timing matters—but the same issue applies to many earlier adoptions.

**Concrete fix:** Recode treatment as “first full calendar year in effect” (and/or use fractional exposure weights based on effective month). Show robustness to both.

### 1.4 Confounding policies and the “policy bundle” problem
Constitutional carry adoptions often coincide with other firearm and criminal-justice changes (preemption expansions, stand-your-ground amendments, permitting changes, policing shifts). The current design attributes all changes to constitutional carry.

Placebos like cancer/heart disease are useful for ruling out broad health shocks, but do not address **gun-policy bundles** that could affect suicide specifically (e.g., safe storage laws, ERPOs, mental health funding, opioid shocks, Medicaid expansions).

**Concrete fix:** Include controls for major contemporaneous gun laws and other key state policies (at minimum: permit-to-purchase, ERPO, stand-your-ground, waiting periods, safe storage/child access prevention, background check expansions, preemption), or run sensitivity checks excluding adoption years with major concurrent firearm-law changes.

### 1.5 Spillovers / SUTVA
You mention spillovers (Strategy/Threats) but do not test them. Cross-border carry and firearm movement could violate SUTVA.

**Concrete fix:** (i) Include border-state exposure measures (share of neighbors treated), (ii) run “donut” analyses excluding border counties/states in a county-level design (if feasible), or (iii) at least show robustness excluding small states with high cross-border commuting.

---

# 2. Inference and statistical validity (critical)

### 2.1 Few treated clusters / cluster-robust SE reliability
Main SEs are clustered by state (e.g., Table 1, Table 2). With 49 clusters overall, asymptotics may be okay, but effective treatment variation in Panel A is driven by **10 treated states**. In that case:
- Conventional clustered SEs can be misleading.
- Randomization inference helps, but the paper’s RI needs to be aligned with staggered adoption structure (see below).

**Must-fix:** Report inference using **wild cluster bootstrap** (state-cluster) for the key Panel A and Panel B estimates (TWFE and Sun-Abraham), and/or randomization inference procedures designed for staggered adoption (e.g., restricted permutations that preserve cohort sizes and timing patterns).

### 2.2 Randomization inference implementation
You “randomly reassign treatment timing across states 500 times” (Results/Randomization Inference). Key concerns:
- If timing is permuted arbitrarily, you may generate placebo assignments that are **not comparable** to the observed adoption process (e.g., too-early adoptions, changing number treated each year).
- With only 500 permutations, p=0.012 is coarse unless you use an exact method or many more draws (minimum attainable two-sided p is 2/500=0.004; still, precision is limited).

**Must-fix:** Clarify the RI design in detail:
- What is held fixed (number of treated states, cohort sizes, adoption years set)?
- Are never-treated statuses preserved?
- Are permutations restricted to feasible adoption years?
Then increase permutations (e.g., 5,000–10,000) and report exact p-value resolution.

### 2.3 Staggered DiD: estimator coherence and the negative CS-DiD
The most serious internal-validity red flag is that in Panel A:
- TWFE: +1.34 (significant)
- Sun-Abraham IW: +0.54 (significant)
- Callaway–Sant’Anna: −0.46 (insignificant), with a **large negative** for Arizona (2010 cohort) (Results/Main Results; Appendix/CS group effects)

A top-journal reader will not accept “CS struggles with the panel’s structure” as sufficient—CS-DiD is specifically designed for staggered adoption. If CS differs because of control-group choice (never-treated only vs never+not-yet) or weighting, that is informative about identification.

**Must-fix:**
1. Re-estimate CS-DiD under multiple control definitions:
   - never-treated only,
   - not-yet-treated only,
   - combined (when feasible under assumptions).
2. Report cohort-weighted aggregations transparently (share of ATT weight by cohort and post periods).
3. Explain why Arizona’s estimated negative effect is credible/not credible (data, measurement, contemporaneous shocks, pre-trends). If one cohort drives sign flips, that must be resolved, not narrated away.

### 2.4 Panel B inference and missingness from suppression
Panel B has suppression-induced missing cells (Data Appendix/Panel Balance). If missingness is correlated with outcomes (small counts more likely in low-violence states), estimates may be non-classical.

**Must-fix:** Show:
- Which states/years are missing for each outcome,
- Whether missingness changes at treatment (event-time missingness plot),
- Robustness using count models where feasible (or restricting to states with complete outcome series).

### 2.5 Multiple testing / researcher degrees of freedom
You test many outcomes (suicide, homicide, firearm suicide, firearm homicide, multiple placebos) and many specifications (TWFE, Sun-Abraham, CS, early adopters, etc.). Some significant findings (e.g., non-firearm homicide decline) could be false positives.

**Fix:** Pre-specify a primary outcome and primary estimator, and report stepdown-adjusted q-values or family-wise error controls for the placebo family.

---

# 3. Robustness and alternative explanations

### 3.1 Robustness to alternative DiD specifications
The paper has several helpful checks (leave-one-cohort-out; Bacon decomposition; placebo outcomes). Missing robustness that is standard for publication readiness:

- **State-specific linear trends** (with caveats): useful as sensitivity, even if not your preferred specification.
- **Region-by-year shocks** (e.g., Census division × year FE) to absorb regional time-varying shocks.
- **Population weighting** vs unweighted (rates already adjusted, but policy relevance often population-weighted).
- **Functional form**: levels vs logs for rates; Poisson pseudo-ML for counts (with exposure).

**Concrete fix:** Add a robustness table with these alternatives and interpret stability of magnitudes.

### 3.2 Alternative explanations specific to suicide
The paper asserts the “carrying margin” mechanism and uses NICS as evidence against an ownership channel (Results/Background Checks). But NICS is a noisy proxy (permit checks, administrative checks, rechecks differ by state), and the paper’s NICS series has a partial year in 2023 (Data Appendix).

**Concrete fix:** Treat NICS results as weak suggestive evidence; add alternative ownership proxies where possible (RAND household gun ownership proxy; suicide firearm share pre-period; hunting license rates) and test whether effects are larger in high-ownership states (heterogeneity).

### 3.3 COVID-era confounding in Panel B
You argue non-firearm placebos absorb “general pandemic mortality effects” (Strategy/Threats), but suicide and firearm violence experienced **specific** pandemic-era shifts that were heterogeneous across states and plausibly correlated with political control (which also predicts adoption).

**Concrete fix:** Add:
- state-specific COVID intensity controls (excess mortality, unemployment shocks),
- year×region fixed effects,
- and show pre-trends in Panel B for adopters vs non-adopters in 2019–2020 (limited but still informative).

### 3.4 Mechanism claims vs reduced form
“Driven entirely by firearms” is too strong given:
- Panel A does not observe firearm suicide,
- Panel B shows firearm suicide increases, but all-cause suicide in Panel B is not significant (Table 2, col 5).

**Concrete fix:** Recalibrate language: Panel B suggests firearm suicides rise; combined with null non-firearm suicide in Panel B, that is *consistent with* a firearm channel, but not definitive for the full 2010–2017 adopting cohorts.

---

# 4. Contribution and literature positioning

### 4.1 Novelty claim likely overstated
The paper claims “first comprehensive causal estimates” (Intro). There is a growing applied literature on permitless carry/constitutional carry and violence outcomes (often criminology/public health). Even if your focus on suicide is novel, you should not claim primacy without a careful search.

**Concrete fix:** Add and engage with:
- Work specifically on **permitless/constitutional carry** (recent public health and criminology studies; also policy reports).
- Broader gun law–suicide causal literature beyond the classic means restriction citations, including quasi-experimental designs around purchase permits, waiting periods, and background checks (you cite Crifasi on MO purchase permits; expand).

### 4.2 Methods literature
You cite Callaway–Sant’Anna, Sun–Abraham, Goodman-Bacon. Also relevant for inference and staggered adoption practice:
- Roth, Sant’Anna, Bilinski, Poe (2023) on pre-trends diagnostics,
- Conley and Taber-style inference issues in DiD with few treated (and modern wild bootstrap references),
- Borusyak, Jaravel, Spiess (2021) imputation estimator as another benchmark.

---

# 5. Results interpretation and claim calibration

### 5.1 Magnitudes and internal consistency
- TWFE implies +1.34/100k; Sun-Abraham implies +0.54/100k; CS is negative.
- The abstract reports “0.5–1.4” which is fine, but later language (“increased suicide rates by roughly 10%,” “devastating,” “driven entirely by firearms”) reads too definitive given estimator divergence.

**Fix:** Make the Sun-Abraham estimate the primary headline (given heterogeneity concerns), present TWFE as a conventional comparator, and treat CS divergence as a central uncertainty that you resolve empirically (not rhetorically).

### 5.2 Policy/welfare calculation is not yet defensible
The welfare section uses TWFE point estimate and strong assumptions on permit holders and fees (Welfare Implications; Table 6). Issues:
- Benefit side ignores deterrence/crime benefits, but also ignores non-monetary benefits of carry (utility to carriers). You acknowledge some of this, but the cost-benefit ratio is presented as “starkly unfavorable” in a way that outstrips what the partial-equilibrium exercise supports.
- Uncertainty in the ATT is not propagated to welfare numbers (no CI).
- Permit holders = 500,000 per state is not sourced credibly and likely varies massively.

**Must-fix:** Either (i) move welfare to appendix and tone down, or (ii) do it properly: show welfare range using Sun-Abraham as primary; compute CIs via delta method/bootstrapping; use administrative estimates of permit counts by state (where available) and state-specific fees; present this explicitly as *illustrative* without strong ratio rhetoric.

---

# 6. Actionable revision requests (prioritized)

## 1) Must-fix issues before acceptance
1. **Resolve estimator inconsistency (CS negative vs Sun-Abraham/TWFE positive).**  
   - *Why:* This is an identification credibility crisis in a staggered DiD paper.  
   - *Fix:* Re-estimate CS under alternative control groups; report cohort weights; diagnose Arizona cohort; add imputation estimator (Borusyak et al.) and show all estimands aligned.

2. **Upgrade inference for few treated clusters and staggered timing.**  
   - *Why:* Standard clustered SEs can be unreliable when only ~10 treated states drive identification.  
   - *Fix:* Wild cluster bootstrap p-values/CIs; staggered-adoption-appropriate RI with restricted permutations; increase permutations.

3. **Correct treatment timing measurement (mid-year implementation).**  
   - *Why:* Annual coding can bias dynamics and “immediate effect” interpretation.  
   - *Fix:* Use first full year treated and/or fractional exposure; show robustness.

4. **Panel B missingness/suppression and COVID-era confounding.**  
   - *Why:* Short window + suppression can distort estimates and standard errors.  
   - *Fix:* Missingness diagnostics; robustness to complete-case states; add region×year FE and COVID shock controls.

## 2) High-value improvements
5. **Add robustness to region-by-year shocks, state trends, and population weighting.**  
   - *Why:* Addresses plausible differential regional trends and strengthens external credibility.  
   - *Fix:* A compact robustness table with consistent reporting.

6. **Strengthen mechanism evidence beyond NICS.**  
   - *Why:* NICS is noisy; mechanism currently inferred rather than tested.  
   - *Fix:* Heterogeneity by baseline gun ownership proxy; alternative ownership measures; if possible, proxy carrying (survey microdata aggregated, or indirect proxies).

7. **Recalibrate claims (“driven entirely by firearms,” strong policy conclusions).**  
   - *Why:* Over-claiming risks rejection even if results are suggestive.  
   - *Fix:* Align language with what Panel A vs Panel B can actually establish; emphasize uncertainty bands.

## 3) Optional polish (substance-adjacent)
8. **Clarify estimand and weighting across cohorts in the main text.**  
   - *Why:* Readers need to know “what average” you are estimating.  
   - *Fix:* Report cohort-time ATT aggregation weights.

9. **Expand and correct literature positioning on permitless carry and suicide/gun-law causal evidence.**  
   - *Why:* Credible novelty claims are essential at AER/QJE/JPE/ReStud/Ecta.  
   - *Fix:* Add missing strands and state precisely what is new.

---

# 7. Overall assessment

### Key strengths
- Important policy question with clear stakes.
- Uses modern staggered DiD tools and includes several valuable diagnostics (event studies, Bacon, leave-one-cohort-out, RI).
- Attempts to separate firearm vs non-firearm outcomes and includes placebo outcomes.

### Critical weaknesses
- Identification is not yet convincing due to **major estimator disagreement** (CS vs Sun-Abraham/TWFE) that is not adequately resolved.
- Inference needs to be robust to **few treated units** and staggered timing.
- Treatment timing measurement and Panel B suppression/COVID confounding require deeper handling.
- Mechanism and welfare/policy claims are currently too strong for the evidentiary base.

### Publishability after revision
Potentially publishable if the authors can (i) deliver a coherent estimand with consistent results across credible staggered-adoption estimators, (ii) provide robust inference, and (iii) tighten treatment timing and Panel B validity. Without that, the paper is unlikely to clear a top general-interest bar.

DECISION: MAJOR REVISION